7. Market Opportunity
Bricopia targets a large existing inventory of stored biological assets and an even larger annual flow of new samples.
Convertible Market for the BRICO System
| Segment | Scale | Note |
|---|---|---|
| Largest US private bank (CBR) | ~$100M / yr | Storage-business revenue |
| Largest China private bank (CO) | ~$140M | Storage business |
| Largest public bank inventory | 60,000 CBU | Single-institution stock |
| Global existing public inventory | 1,000,000 CBU | ≈ $50B existing convertible market |
| Annual new storage, approximately 10% of newborns | N/A | ≈ $500B / yr incremental market |
The near-term opportunity is to unlock the roughly US$50 billion of existing public-bank inventory that is currently illiquid. Over time, capturing even a fraction of the approximately US$500 billion of biological assets created annually represents a very large addressable market for tokenization.
Addressable Market
| Market category | Estimated value |
|---|---|
| Largest public bank inventory, 60k CBU | $3B |
| Global existing public inventory, 1M CBU | $50B |
| Annual new storage, approximately 10% of births | $500B / yr |
Why Now
The combination of a supportive 2025 regulatory environment for stablecoins and RWAs, and Bricopia's unique position as the only FDA-registered automation supplier, creates a rare window to establish the category.